Table 2 Clinical characteristics of the 6 cCLD patients who decompensated the year after sampling.

From: microRNA associated with hepatocyte injury and systemic inflammation may predict adverse outcomes in cirrhotic patients

Variable

Number (%) or median (IQR)

Age

54 (43–64)

Sex (male)

4 (66.67%)

ARLD

3 (50%)

Active alcohol consumption

1 (16.67%)

WCC (× 109/l)

3.68 (1.95–5.32)

Hb (g/dl)

111.50 (107.75–148.25)

Platelets (× 109/l)

71.00 (49.00–181.75)

INR

1.23 (1.10–1.36)

CRP (mg/L)

3.25 (1.75–11.38)

Bilirubin (mg/dl)

1.29 (0.85–1.46)

AST (U/L)

43.50 (29.00–71.00)

Albumin (g/L)

37.50 (30.75–43.25)

Na (mmol/L)

140 (136.250142)

Creatinine (mg/dl)

0.70 (0.61–0.95)

Ammonia (µmol/L)

77.50 (31.25–125.50)

Any ascites

0 (0%)

Any HE

1 (16.67%)

MELD score

10.00 (8.00–11.25)

Child Pugh score

5.50 (5.00–6.00)